US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

110.49

+1.311.20%

Post-market: 110.24-0.2500-0.23%19:35 EDT

Volume:273.50K

Turnover:30.13M

Market Cap:1.03B

PE:89.53

High:110.70

Open:109.16

Low:108.66

Close:109.18

52wk High:118.00

52wk Low:90.60

Shares:9.34M

Float Shares:9.34M

Volume Ratio:0.90

T/O Rate:2.93%

Dividend:2.14

Dividend Rate:1.94%

EPS(TTM):1.23

EPS(LYR):0.7765

ROE:--

ROA:--

PB:--

PE(LYR):142.30

Loading ...

Overview Company News Filings

AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense

Abbvie - Full-Year 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $13.76-$13.96 - SEC Filing

THOMSON REUTERS

Abbvie - Q3 2026 Gaap and Adj Earnings Include $216 Mln Bought Ipr&D and Milestones Expense - SEC Filing

THOMSON REUTERS

Abbvie Inc. Fy2026 Shr View $14.02

THOMSON REUTERS

Abbvie - Q3 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $3.73-$3.77 - SEC Filing

THOMSON REUTERS

Genmab, AbbVie Say New Drug Combo Helps Lymphoma Patients Stay Cancer-Free Longer

MT Newswires Live

Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCL

AbbVie Blood Cancer Drug Combo Cuts Risk of Progression or Death in Late-Stage Study

Genmab, AbbVie report epcoritamab combination demonstrates improved PFS in study

Genmab Says Phase 3 Epcore DLBCL-2 Trial Shows Epcoritamab Plus R-CHOP Cuts Progression or Death Risk 51% in Newly Diagnosed DLBCL

Genmab - Phase 3 Trial Shows 51% Reduction in Risk of Progression or Death in Dlbcl

THOMSON REUTERS

Genmab: Safety Profile of Epcoritamab When Administered in Combination with Standard of Care R-Chop was Generally Well Tolerated

THOMSON REUTERS

Genmab and Abbvie Announce Epcoritamab in Combination with R-Chop Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

THOMSON REUTERS

Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.47%

Novartis AG Rises Monday, Underperforms Market

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Lilly Expands Oncology Footprint with FDA Win for Pancreatic Cancer Drug

Eli Lilly treatment of pancreatic cancer granted orphan designation

Analysts’ Top Healthcare Picks: Novartis (NVS), Crescent Biopharma (CBIO)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/PPH/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","market":"US","secType":"STK","nameCN":"VanEck Pharmaceutical ETF","latestPrice":110.49,"timestamp":1791576000000,"preClose":109.18,"halted":0,"volume":273495,"hourTrading":{"tag":"盘后","latestPrice":110.24,"preClose":110.49,"latestTime":"19:35 EDT","volume":298,"amount":32899.702,"timestamp":1791588903183,"change":-0.25,"changeRate":-0.002263,"amplitude":0.002353},"delay":0,"changeRate":0.011998534530133614,"floatShares":9338138,"shares":9338138,"eps":1.234146,"marketStatus":"Market Closed","change":1.31,"latestTime":"10-09 16:00:00 EDT","open":109.16,"high":110.7,"low":108.66,"amount":30133911.57075,"amplitude":0.018685,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.234146,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":109.18,"sharesOutstanding":11938138,"nav":109.21648,"aum":1025339382.73,"dividendRate":0.019367,"bidAskSpread":0.000386,"preHourTrading":{"tag":"盘前","latestPrice":109,"preClose":109.18,"latestTime":"09:29 EDT","volume":297,"amount":32387.438654999998,"timestamp":1791552596078,"change":-0.18,"changeRate":-0.001649,"amplitude":0.002565},"postHourTrading":{"tag":"盘后","latestPrice":110.24,"preClose":110.49,"latestTime":"19:35 EDT","volume":298,"amount":32899.702,"timestamp":1791588903183,"change":-0.25,"changeRate":-0.002263,"amplitude":0.002353},"volumeRatio":0.9003998049011747,"impliedVol":0.2519,"impliedVolPercentile":0.9562},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","floatShares":9338138,"roa":"--","roe":"--","lyrEps":0.776475,"volumeRatio":0.9003998049011747,"shares":9338138,"dividePrice":2.1399,"high":110.7,"amplitude":0.018685,"preClose":109.18,"low":108.66,"week52Low":90.6,"pbRate":"--","week52High":118,"institutionHeld":0,"latestPrice":110.49,"eps":1.234146,"divideRate":0.019367,"volume":273495,"delay":0,"ttmEps":1.234146,"open":109.16,"prevYearClose":103.17,"prevWeekClose":108.06,"prevMonthClose":109.47,"prevQuarterClose":109.47,"fiveDayClose":108.06,"twentyDayClose":109.44,"sixtyDayClose":109.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPH\",params:#limit:5,,,undefined,":[{"date":"2026-10-01","symbol":"PPH","amount":0.36,"announcedDate":"2026-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-10-01","defaultRemindTime":1790861400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-06","payableDate":"2026-10-01","currency":"USD","dateTimestamp":1790827200000,"payDate":"2026-10-06"},{"date":"2026-07-01","symbol":"PPH","amount":0.6248,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-07"},{"date":"2026-04-01","symbol":"PPH","amount":0.8441,"announcedDate":"2026-03-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-01","defaultRemindTime":1775050200000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-07","payableDate":"2026-04-01","currency":"USD","dateTimestamp":1775016000000,"payDate":"2026-04-07"},{"date":"2025-12-29","symbol":"PPH","amount":0.3106,"announcedDate":"2025-12-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-29","defaultRemindTime":1767018600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-29","currency":"USD","dateTimestamp":1766984400000,"payDate":"2025-12-31"},{"date":"2025-10-01","symbol":"PPH","amount":0.3931,"announcedDate":"2025-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-01","defaultRemindTime":1759325400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-06","payableDate":"2025-10-01","currency":"USD","dateTimestamp":1759291200000,"payDate":"2025-10-06"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.1449,"currency":"USD"},{"executeDate":"2017-04-03","recordDate":"2017-04-05","paymentDate":"2017-04-07","value":0.4651,"currency":"USD"},{"executeDate":"2017-07-03","recordDate":"2017-07-06","paymentDate":"2017-07-10","value":0.304,"currency":"USD"},{"executeDate":"2017-10-02","recordDate":"2017-10-03","paymentDate":"2017-10-06","value":0.221,"currency":"USD"},{"executeDate":"2018-04-02","recordDate":"2018-04-03","paymentDate":"2018-04-06","value":0.3943,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPH\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673081209","title":"AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081209","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081209?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:09","pubTimestamp":1791230948,"startTime":"0","endTime":"0","summary":"AbbVie cuts Q3 adjusted diluted EPS outlook to $3.73-$3.77 after $216 million acquired IPR&D, milestones expenseAbbVie cut Q3 2026 adjusted diluted EPS guidance to USD 3.73–3.77 from USD 3.84–3.88, re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLbW9K2t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","SG9999015978.USD","BK4550","GLAM","IE000SO60NU8.SGD","LU1236620750.USD","FHLC","IYH","LU0122379950.USD","LU0943347566.SGD","LU0553294199.USD","LU1934455863.HKD","LU0320765646.SGD","BK4588","FTXH","LU0170899867.USD","BK4534","LU1732799900.SGD","LU2023251221.USD","IE00B3PB1722.GBP","LU1037948541.HKD","MEDX","LU1720051108.HKD","LU1585245621.USD","LU0158827948.USD","LU1430594728.SGD","LU1023059063.AUD","XLV","ABBV","LU1162221912.USD","LU0661504455.SGD","LU1236620834.HKD","LU1267930573.SGD","IE0002141913.USD","IE0004445239.USD","JDOC","IXJ","TRUH","IE000BZT7R73.USD","LU0203345920.USD","PPH","RXL","IE00BGHQF631.EUR","PJP","VHT","LU2237443978.SGD","AGNG","IE00BDGV0183.EUR","LU0234570918.USD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673812780","title":"Abbvie - Full-Year 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $13.76-$13.96 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673812780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673812780?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2023251221.USD","BK4534","LU1585245621.USD","LU0122379950.USD","BK4550","LU1267930573.SGD","JDOC","SG9999015978.USD","IXJ","MEDX","LU1934455863.HKD","RXL","ABBV","IE00B3PB1722.GBP","IE00BDGV0183.EUR","BK4566","LU0170899867.USD","LU1162221912.USD","LU1732799900.SGD","LU2237443978.SGD","TRUH","IYH","IE000BZT7R73.USD","AGNG","LU0128525929.USD","BK4588","XLV","LU1037948541.HKD","IE0004445239.USD","PPH","PJP","LU0661504455.SGD","IE0002141913.USD","IE00BGHQF631.EUR","FTXH","LU1720051108.HKD","LU0158827948.USD","FHLC","LU0320765646.SGD","LU1023059063.AUD","LU0553294199.USD","VHT","LU1236620750.USD","LU0943347566.SGD","LU0234570918.USD","LU1236620834.HKD","LU0203345920.USD","LU1430594728.SGD","IE000SO60NU8.SGD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673220081","title":"Abbvie - Q3 2026 Gaap and Adj Earnings Include $216 Mln Bought Ipr&D and Milestones Expense - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673220081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673220081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0211327993.USD","LU0738911758.USD","LU1585245621.USD","BK4139","JDOC","LU1720051017.SGD","PPH","IXJ","LU0708994859.HKD","LU1551013425.SGD","LU0689626769.HKD","IE00BGHQF631.EUR","LU2087621335.USD","AGNG","XLV","MEDX","LU1267930573.SGD","LU0114720955.EUR","PJP","GLAM","LU0795875169.SGD","LU0912757837.SGD","LU1496350502.SGD","IYH","TRUH","LU2237443978.SGD","LU0823416689.USD","FHLC","LU2129689431.USD","LU0795875086.SGD","LU0124676726.USD","LU0417517546.SGD","LU2237443895.HKD","BK4581","LU0058720904.USD","IE00BSNM7G36.USD","FTXH","LU0158827948.USD","LU2357305700.SGD","LU0545039389.USD","LU0553294199.USD","LU1061106388.HKD","BK4534","LU0661504455.SGD","LU1003077747.HKD","LU1244550577.SGD","RXL","VHT","LU0203347892.USD","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081273","title":"Abbvie Inc. Fy2026 Shr View $14.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081273?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FTXH","MEDX","LU1003077747.HKD","LU0943347566.SGD","FHLC","PJP","ABBV","LU0122379950.USD","LU1983299246.USD","LU1732799900.SGD","IE00BJT1NW94.SGD","LU1720051108.HKD","LU0965509010.AUD","IE00B3PB1722.GBP","AGNG","GLAM","LU1061106388.HKD","LU0738911758.USD","LU1923622614.USD","BK4581","JDOC","LU2125909593.SGD","LU0417517546.SGD","LU1989772923.USD","LU2237443465.HKD","LU1057294990.SGD","SG9999003800.SGD","LU0098860793.USD","LU2125909247.SGD","LU2237443549.SGD","RXL","IXJ","LU1718418525.SGD","SG9999015952.SGD","LU0203345920.USD","TRUH","LU0058720904.USD","VHT","IYH","LU0256863902.USD","LU1267930573.SGD","LU2237443622.USD","LU1093756168.USD","PPH","XLV","LU2347655073.USD","LU0859254822.USD","LU0057025933.USD","SG9999015978.USD","IE0004445239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081227","title":"Abbvie - Q3 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $3.73-$3.77 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081227","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081227?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2347655073.USD","IE00BN8TJ469.HKD","JDOC","LU1839511570.USD","PPH","LU2112291526.USD","IXJ","LU1934455194.USD","LU1023059063.AUD","LU1718418525.SGD","LU0949170772.SGD","AGNG","XLV","IE00B3PB1722.GBP","MEDX","PJP","GLAM","LU0256863811.USD","LU1244550221.USD","LU1496350502.SGD","IYH","LU2125909593.SGD","TRUH","FHLC","LU0395794307.EUR","LU0170899867.USD","LU2237443465.HKD","IE00BLSP4452.SGD","LU2237443622.USD","BK4581","LU0058720904.USD","FTXH","LU0511384066.AUD","LU0472753341.HKD","LU2237443382.USD","LU1236620750.USD","LU0289961442.SGD","SG9999001440.SGD","BK4534","LU0861579265.USD","LU2089283258.USD","LU1929549753.HKD","RXL","SG9999015945.SGD","VHT","LU1037948897.HKD","IE00B19Z3B42.SGD","ABBV","LU0689472784.USD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673819760","title":"Genmab, AbbVie Say New Drug Combo Helps Lymphoma Patients Stay Cancer-Free Longer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673819760","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673819760?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:50","pubTimestamp":1791229824,"startTime":"0","endTime":"0","summary":"Genmab  and AbbVie  said that adding their drug epcoritamab to a standard chemotherapy mix helped people with an aggressive form of blood cancer stay cancer-free longer than chemotherapy alone.The combination cut the risk of the cancer getting worse or the patient dying by 51% compared with standard treatment alone, the companies said Monday in a statement. Results were from a large study in newly diagnosed patients with diffuse large B-cell lymphoma, the most common type of non-Hodgkin lymphoma.The treatment paired epcoritamab with R-CHOP, a long-used chemotherapy regimen. The companies said the safety of the combination looked generally similar to what doctors already expect from each drug on its own.Because the treatment is still experimental, Genmab and AbbVie plan to meet with regulators around the world to discuss next steps.Genmab shares rose 11% in Monday trading, and AbbVie gained 1.3%.Price: 38.72, Change: +3.97, Percent Change: +11.41","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128525929.USD","LU0942090050.USD","LU0965509101.SGD","LU1244550221.USD","LU1839511570.USD","IE00BLSP4239.USD","IYH","LU1989772840.SGD","LU2347655156.SGD","LU0689626769.HKD","LU2125909593.SGD","GMAB","JDOC","FHLC","ABBV","RXL","IE00BSNM7G36.USD","LU2129689605.HKD","PPH","TRUH","IE000MB6IJN5.SGD","XLV","LU0158827948.USD","LU1162221912.USD","BK4581","IE00BVYPNW00.USD","IE00BN8TJ469.HKD","SG9999003800.SGD","LU2237443549.SGD","GLAM","MEDX","IXJ","LU0795875169.SGD","LU2089284900.SGD","LU0256863811.USD","PJP","LU1983299246.USD","LU0395794307.EUR","IE00B4R5TH58.HKD","LU2089283258.USD","LU1057294990.SGD","LU2237443382.USD","LU2347655073.USD","VHT","LU1923622614.USD","LU2237443465.HKD","LU0859254822.USD","FTXH","SG9999015945.SGD","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673811030","title":"Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2673811030","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673811030?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:47","pubTimestamp":1791229638,"startTime":"0","endTime":"0","summary":"An announcement from Genmab ( ($GMAB) ) is now available. Genmab and AbbVie reported on October 5, 2026, that their Phase 3 EPCORE DLBCL-2 trial sh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genmab-and-abbvie-report-landmark-phase-3-win-for-epcoritamab-combo-in-frontline-dlbcl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genmab-and-abbvie-report-landmark-phase-3-win-for-epcoritamab-combo-in-frontline-dlbcl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0456855351.SGD","PJP","RXL","TRUH","LU2468319806.SGD","IXJ","LU1037948897.HKD","LU1718418525.SGD","XLV","LU0823416689.USD","PPH","BK4581","BK4559","LU1236620750.USD","AGNG","LU0689626769.HKD","IE000SO60NU8.SGD","LU1929549753.HKD","LU2089284900.SGD","LU0158827948.USD","LU2237443978.SGD","BK4588","LU2237443382.USD","GLAM","FTXH","BK4585","LU1496350502.SGD","LU1551013342.USD","ABBV","FHLC","LU2237443465.HKD","LU2357305700.SGD","IE00B4R5TH58.HKD","LU1037948541.HKD","LU0122379950.USD","LU1670628061.USD","IE00B3PB1722.GBP","IE00BDGV0183.EUR","IE000F7OJYX1.SGD","LU0965509101.SGD","VHT","LU0289739699.SGD","BK4550","LU0965509283.SGD","IYH","JDOC","LU1244550221.USD","LU1074936037.SGD","LU1720051017.SGD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673363081","title":"AbbVie Blood Cancer Drug Combo Cuts Risk of Progression or Death in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673363081","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673363081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:36","pubTimestamp":1791228977,"startTime":"0","endTime":"0","summary":"AbbVie blood cancer drug combo cuts risk of progression or death in late-stage studyOct 5 (Reuters)-Danish biotech firm GenmabGMAB.COand US drugmaker AbbVieABBV.Nsaid on Monday their combination treat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nL4N45R185:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089283258.USD","LU1244550221.USD","LU0395794307.EUR","ABBV","GLAM","LU0158827948.USD","IE00BSNM7G36.USD","IXJ","LU1989772840.SGD","LU2237443382.USD","LU2347655156.SGD","TRUH","SG9999003800.SGD","LU1162221912.USD","LU0942090050.USD","SG9999015945.SGD","IE00BFTCPJ56.SGD","LU0859254822.USD","VHT","LU1983299246.USD","XLV","LU2129689605.HKD","MEDX","RXL","BK4581","FHLC","IE00B4R5TH58.HKD","IE00BLSP4239.USD","LU1923622614.USD","LU2125909593.SGD","LU0689626769.HKD","IYH","LU2237443549.SGD","LU2089284900.SGD","LU1057294990.SGD","PJP","FTXH","LU0795875169.SGD","IE00BN8TJ469.HKD","IE00BVYPNW00.USD","AGNG","LU1839511570.USD","IE000MB6IJN5.SGD","LU0256863811.USD","LU2237443465.HKD","LU0965509101.SGD","LU0128525929.USD","LU2347655073.USD","PPH","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673311081","title":"Genmab, AbbVie report epcoritamab combination demonstrates improved PFS in study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673311081","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673311081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:55","pubTimestamp":1791226515,"startTime":"0","endTime":"0","summary":"Genmab A/S (GMAB) and AbbVie (ABBV) announced “positive” topline results from the Phase 3 EPCORE DLBCL-2 trial evaluating fixed treatment duration ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genmab-abbvie-report-epcoritamab-combination-demonstrates-improved-pfs-in-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genmab-abbvie-report-epcoritamab-combination-demonstrates-improved-pfs-in-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525929.USD","LU1551013342.USD","LU2433249047.HKD","LU0456855351.SGD","TRUH","LU2089284900.SGD","LU1934455194.USD","GMAB","AGNG","LU1074936037.SGD","RXL","LU1267930490.SGD","LU0511384066.AUD","VHT","SG9999001440.SGD","FTXH","LU0395794307.EUR","LU0726765562.USD","IYH","LU0289739699.SGD","LU0211328371.USD","IXJ","LU0868494617.USD","LU1585245621.USD","LU2087621335.USD","LU0203345920.USD","LU0256863902.USD","MEDX","LU0058720904.USD","LU1720051108.HKD","LU2023251221.USD","PJP","SG9999015986.USD","LU2357627491.SGD","IE00BJT1NW94.SGD","PPH","IE000MB6IJN5.SGD","LU1496350171.SGD","LU0069063385.USD","LU0057025933.USD","LU2125909593.SGD","FHLC","GLAM","LU0417517546.SGD","LU1023059063.AUD","LU1934455277.USD","LVIG","XLV","JDOC","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673089429","title":"Genmab Says Phase 3 Epcore DLBCL-2 Trial Shows Epcoritamab Plus R-CHOP Cuts Progression or Death Risk 51% in Newly Diagnosed DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2673089429","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673089429?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:50","pubTimestamp":1791226259,"startTime":"0","endTime":"0","summary":"Genmab says Phase 3 EPCORE DLBCL-2 trial shows epcoritamab plus R-CHOP cuts progression or death risk 51% in newly diagnosed DLBCLGenmab, AbbVie reported positive topline Phase 3 results for epcoritam","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLWBPbl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","IE00B19Z3B42.SGD","LU1585245621.USD","AGNG","LU0320765646.SGD","LU2468319806.SGD","IE000SO60NU8.SGD","IE000WAW04H5.SGD","FHLC","IE00BKPKM429.USD","LU0310799852.SGD","IE00BJT1NW94.SGD","BK4550","FTXH","XLV","LU2095319765.USD","LU0234570918.USD","TRUH","BCDF","LU0158827948.USD","ABBV","BK4581","IE00BN0W2V16.EUR","LU0289961442.SGD","LU0912757837.SGD","PJP","JDOC","LU1720051017.SGD","MEDX","IE00B2B36J28.USD","LU0114720955.EUR","LU0859254822.USD","IE00B19Z3581.USD","RXL","IXJ","IE00BQXX3F31.USD","LU1003077747.HKD","PPH","IYH","VHT","LU0198837287.USD","LU0943347566.SGD","IE00BGHQF748.EUR","LU1923622614.USD","LU0882574055.USD","BK4588","LU1989771016.USD","NDAQ","LU2089283258.USD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673894940","title":"Genmab - Phase 3 Trial Shows 51% Reduction in Risk of Progression or Death in Dlbcl","url":"https://stock-news.laohu8.com/highlight/detail?id=2673894940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673894940?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:49","pubTimestamp":1791226144,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1GV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","IE00B19Z3B42.SGD","LU0456855351.SGD","LU1585245621.USD","AGNG","LU0320765646.SGD","LU2468319806.SGD","IE000SO60NU8.SGD","IE000WAW04H5.SGD","FHLC","LU0310799852.SGD","IE00BJT1NW94.SGD","BK4550","LU1551013425.SGD","FTXH","XLV","LU0234570918.USD","TRUH","LU0158827948.USD","ABBV","BK4581","LU0289961442.SGD","LU0912757837.SGD","IE0000B7K699.USD","PJP","JDOC","LU1720051017.SGD","MEDX","IE00BBT3K403.USD","IE00B2B36J28.USD","LU0114720955.EUR","LU0859254822.USD","IE00B19Z3581.USD","RXL","LU0965509010.AUD","IXJ","LU1003077747.HKD","PPH","IYH","VHT","LU0198837287.USD","LU0943347566.SGD","LU1923622614.USD","LU0882574055.USD","BK4588","LU1267930573.SGD","LU0553294199.USD","LU1989771016.USD","LU2089283258.USD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673894110","title":"Genmab: Safety Profile of Epcoritamab When Administered in Combination with Standard of Care R-Chop was Generally Well Tolerated","url":"https://stock-news.laohu8.com/highlight/detail?id=2673894110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673894110?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:49","pubTimestamp":1791226144,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1GV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0965509101.SGD","LU2023251221.USD","LU0738911758.USD","IE0004445239.USD","LU1244550577.SGD","BK4566","JDOC","LU1551013425.SGD","IE00BJJMRZ35.SGD","PPH","LU0795875086.SGD","LU0256863811.USD","LU2237443382.USD","TRUH","LU1548497426.USD","MEDX","RXL","BK4559","GLAM","LU0861579265.USD","ABBV","LU0128525929.USD","PJP","IE00BVYPNV92.GBP","LU0417517546.SGD","LU0708994859.HKD","LU1037948541.HKD","FTXH","XLV","IYH","LU2357627491.SGD","AGNG","FHLC","LU0456855351.SGD","LU0795875169.SGD","SG9999015952.SGD","VHT","BK4534","LU0868494617.USD","LU2129689605.HKD","LU0256863902.USD","LU0234570918.USD","IE00BJT1NW94.SGD","LU0689626769.HKD","BK4550","LU1934455194.USD","LU1989772923.USD","LU1934455277.USD","IXJ","LU0949170772.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673089491","title":"Genmab and Abbvie Announce Epcoritamab in Combination with R-Chop Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2673089491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673089491?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:49","pubTimestamp":1791226144,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1GV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PJP","RXL","VHT","LU0320765646.SGD","IE000BZT7R73.USD","IXJ","ABBV","LU2237443382.USD","LU1585245621.USD","TRUH","MEDX","LU0868494708.USD","LU1267930490.SGD","IE00BVYPNW00.USD","LU0965509101.SGD","LU1551013342.USD","LU2089984988.USD","IE000SO60NU8.SGD","GLAM","IYH","LU2087621335.USD","LU2089284900.SGD","LU1989772840.SGD","FHLC","LU1934455277.USD","LU1934455863.HKD","LU1093756168.USD","IE00B3PB1722.GBP","LU2433249047.HKD","IE00B19Z3B42.SGD","LU2129689605.HKD","LU0511384066.AUD","LU1923622614.USD","FTXH","LU0868494617.USD","XLV","LU1037948897.HKD","LU1236620750.USD","LU1267930573.SGD","LU0820561909.HKD","PPH","BK4585","LU2112291526.USD","LU2129689514.USD","JDOC","LU1023059063.AUD","LU0823416689.USD","AGNG","LU1720051108.HKD","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673408917","title":"Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2673408917","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673408917?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:35","pubTimestamp":1791225314,"startTime":"0","endTime":"0","summary":"The stock of Eli Lilly ($LLY) is up about 1% on Oct. 5 after the company secured a regulatory win for one of its experimental cancer drugs called O...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-gains-on-regulatory-win-for-experimental-cancer-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-gains-on-regulatory-win-for-experimental-cancer-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999014898.SGD","LU0323591593.USD","LU2491049909.HKD","LU2746668461.USD","LU2491050071.SGD","LU0823434583.USD","LU2237443382.USD","PPH","LU1629891620.HKD","JDOC","FHLC","LU1917777945.USD","LU0823434740.USD","LU0354030511.USD","LU2265009873.SGD","LU0256863811.USD","FTXH","IE00BJLML261.HKD","LU0079474960.USD","LU2089283258.USD","LU2324357040.USD","LU2750360997.AUD","SG9999017495.SGD","LU1291159041.SGD","IE00B1BXHZ80.USD","LU0786609619.USD","BK4581","LU1712237335.SGD","LU0061475181.USD","LU2361044865.SGD","LU2361045086.USD","LU0203202063.USD","SG9999014880.SGD","LU2361044949.HKD","LU2023251221.USD","SGXZ51526630.SGD","LU2237443549.SGD","LU0114720955.EUR","LU0353189763.USD","SG9999014906.USD","SGXZ99366536.SGD","IE0002141913.USD","LLY","LU0820561909.HKD","LU0964807845.USD","IE0009355771.USD","IE00B775H168.HKD","LU2552382215.SGD","LU1093756168.USD","LU0640476718.USD","IE00BJJMRX11.SGD","IE00BKDWB100.SGD","BK4588","LU0354030438.USD","SGXZ31699556.SGD","LU0122379950.USD","LU0096364046.USD","LU0210536198.USD","LU2106854487.HKD","BK4533","IE00BJJMRZ35.SGD","LU2168564065.EUR","BK4007","LU0820562030.AUD","LU0466842654.USD","LU2552382058.USD","IE00BK4W5M84.HKD","LU0198837287.USD","LU1057294990.SGD","LU2168564222.USD","IE00BFTCPJ56.SGD","LU0203201768.USD","LU0316494557.USD","LU0471298694.HKD","LU2168564495.EUR","LU2271345857.HKD","LU1127390331.HKD","AGNG","LU0385154629.USD","RXL","IE0005OL40V9.USD","LU0708995401.HKD","LU0094547139.USD","LU2756315664.SGD","LU2471134796.USD","SG9999015986.USD","LU0225283273.USD","LU0320765059.SGD","LU1814569148.SGD","LU1868837136.USD","THNR","LU2112291526.USD","OZEM","GB00BDT5M118.USD","LU1069344957.HKD","LU2471134523.USD","SG9999018857.SGD","LU2213496289.HKD","LU1868836591.USD","LU2237443978.SGD","LU2028103732.USD","LU0882574055.USD","LU2089984988.USD","LU2456880835.USD","LU2417539215.USD","IE00B2B36J28.USD","LU0234572021.USD","SGXZ57979304.SGD","LU0787776722.HKD","MHIP","LU1023059063.AUD","LLYX","IE00BWXC8680.SGD","LU0109394709.USD","LU0672654240.SGD","LU2087625088.SGD","LU0158827781.USD","LU2237438978.USD","LU0109391861.USD","LU1691799644.USD","SG9999014914.USD","LU1093756325.SGD","LU1720051108.HKD","SG9999001176.SGD","LU2896262040.SGD","IE00BFSS7M15.SGD","MEDX","LU2168564149.EUR","LU1323610961.USD","LU2237443895.HKD","WDNA","ELIS","LU2462591350.SGD","BK4599","SG9999018865.SGD","LU0256863902.USD","LU1551013425.SGD","LU2108987350.USD","LU2756315318.SGD","LU0238689110.USD","LU0345770308.USD","LU2211815571.USD","PJP","LU2462157665.USD","LU0320765992.SGD","LU0345770993.USD","LU1366192091.USD","LU2750360641.GBP","SGXZ81514606.USD","LU0820561818.USD","LLII","LU1061106388.HKD","LU1145028129.USD","LU2111349929.HKD","IE00BFSS8Q28.SGD","LU0417517546.SGD","LU2237443622.USD","LU2237443465.HKD","LU1720051017.SGD","LU1974910355.USD","IE00BKPKM429.USD","LU2491050154.USD","LU2552382132.HKD","SG9999015952.SGD","LU2746668974.SGD","LU0456855351.SGD","LU0106261372.USD","LU2063271972.USD","VHT","XLV","BK4534","LU2023250330.USD","LU1979441026.SGD","LU1548497426.USD","LU0289739699.SGD","LU0158827948.USD","HRTS","LU0943347566.SGD","LU1551013342.USD","LU0174119429.USD","LU0006306889.USD","IE00B4JS1V06.HKD","SG9999013999.USD","LU0689472784.USD","SG9999015945.SGD","SG9999001176.USD","CANC","IE0001KFT4U8.USD","IE00BJJMRY28.SGD","LU1983299246.USD","LU2468319806.SGD","LLYZ","LU0823416689.USD","LU1064131342.USD","LU1623119135.USD","IE00B7KXQ091.USD","TMED","BK4585","LU2357305700.SGD","LU1267930730.SGD","LU0471298777.SGD","LU2360106947.USD","LU1232071149.USD","LU1868836757.USD","LU1989771016.USD","LU2023250504.SGD","IHE","LU2264538146.SGD","ILDR","LU1280957306.USD","LU0882574139.USD","LU2471134952.CNY","LU2236285917.USD","GDOC","IE00B4R5TH58.HKD","IYH","LU0266013472.USD","LU0889565916.HKD","IE00B1XK9C88.USD","IE00BK4W5L77.USD","LU0432979614.USD","BK4516","LU1035775433.USD","IE00BN29S564.USD","LU1804176565.USD","LU0097036916.USD","MEDI","CURE","IE00BJT1NW94.SGD","LU0058720904.USD","LU2168563687.JPY","IE0004445015.USD","LU1988902786.USD","LU2602419157.SGD","LU1868836914.USD","LU0683600562.USD","LU2471134879.HKD","ELIL","TRUH","LU2089284900.SGD","LU2461242641.AUD","LU0133085943.USD","LU0353189680.USD","SG9999015978.USD","IE0004445239.USD","IXJ","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673086789","title":"Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673086789","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673086789?lang=en_us&edition=fundamental","pubTime":"2026-10-06 01:15","pubTimestamp":1791220511,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares down 18c near $37.15. Options volume relatively light with 24k contracts...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-down-0-47-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-down-0-47-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","NVOH","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO","THNR","LU1093756325.SGD","BK4007","BK4532","LU1093756168.USD","OZEM","BK4585","PPH","NVOC","BK4599","NVOX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085063","title":"Novartis AG Rises Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085063","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085063?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:15","pubTimestamp":1791216900,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  rose 0.1% to CHF116.48 Monday on what proved to be an overall favorable trading session for the stock market, with the Swiss Market Index SMI Index  rising 0.3% to 13,703.53.Novartis AG closed CHF16.20 below its 52-week high of CHF132.68, which the company achieved on September 3, 2026.Trading volume was 2,407,594, compared to the 50-day average trading volume of 2,856,042.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0208291251.USD","IE00BFTCPJ56.SGD","NVS","BK4585","LU0211331839.USD","IE00BJT1NW94.SGD","BK4007","PPH","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00B4R5TH58.HKD","LU0320765489.SGD","MEDX","LU0070302665.USD","BK4578","BK4588","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085403","title":"Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085403","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085403?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:03","pubTimestamp":1791216180,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B shed 0.8% to DKK246.80 Monday on what proved to be an overall mediocre trading session for the stock market, with the OMX Nordic 40 Index holding steady at 2,595.90.This was the stock's third consecutive day of losses.The company closed DKK163.15 below its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 5,784,986, compared to the 50-day average trading volume of 4,924,415.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","LU0154236417.USD","NVOX","BK4585","PPH","OZEM","BK4007","LU1093756325.SGD","THNR","NVOH","BK4532","BK4599","IE00BKVL7J92.USD","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085966","title":"Lilly Expands Oncology Footprint with FDA Win for Pancreatic Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085966","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085966?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:44","pubTimestamp":1791215040,"startTime":"0","endTime":"0","summary":"Another day, another chance for Eli Lilly to prove it is more than just a leader in weight-loss drugs. That validation came in the form of a regulatory win for its experimental cancer treatment, olomo","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443549.SGD","GDOC","JDOC","LU0234572021.USD","LU0354030511.USD","LU2089284900.SGD","LU2168564065.EUR","LU0323591593.USD","LU2213496289.HKD","LU2750360997.AUD","BK4007","LU0114720955.EUR","SGXZ51526630.SGD","SG9999014898.SGD","LU0203201768.USD","LU2491050071.SGD","IE00B1BXHZ80.USD","IE00BJJMRX11.SGD","LU0456855351.SGD","LU0683600562.USD","LU2023250330.USD","SG9999014906.USD","IE0009355771.USD","LU2271345857.HKD","LU1280957306.USD","LU2237443465.HKD","LU2471134879.HKD","MEDI","IE00B7KXQ091.USD","GB00BDT5M118.USD","BK4581","LU0320765059.SGD","LU1035775433.USD","LU2746668461.USD","LU2168564495.EUR","IE00BK4W5M84.HKD","LU2236285917.USD","LU2471134952.CNY","LU2108987350.USD","LU0096364046.USD","LU0689472784.USD","LU0820561909.HKD","LU2087625088.SGD","IE0004445015.USD","LU0094547139.USD","LU2211815571.USD","LU2456880835.USD","BK4516","LU1691799644.USD","LU2112291526.USD","LU1366192091.USD","SG9999018865.SGD","LU2491049909.HKD","LU0385154629.USD","LU0345770308.USD","LU1548497426.USD","SG9999013999.USD","LU0316494557.USD","LU1069344957.HKD","LU1629891620.HKD","IE00B1XK9C88.USD","CURE","LU0466842654.USD","LU2361045086.USD","LU1983299246.USD","IE0001KFT4U8.USD","ELIS","LU0266013472.USD","LU1267930730.SGD","LU0109391861.USD","LU1551013425.SGD","LU1974910355.USD","LU2265009873.SGD","IE00BFTCPJ56.SGD","LU2491050154.USD","LU0158827781.USD","TMED","LU0106261372.USD","LU0225283273.USD","LU2461242641.AUD","LU1868836757.USD","LU0417517546.SGD","LU0353189680.USD","LU1804176565.USD","LU1712237335.SGD","LU2023251221.USD","PJP","LU0133085943.USD","IYH","LU2462157665.USD","VHT","LU0210536198.USD","BK4534","LU2471134523.USD","LU0320765992.SGD","LU0061475181.USD","IE00BWXC8680.SGD","LU0238689110.USD","LU2111349929.HKD","LU1064131342.USD","LU0122379950.USD","IE00BJJMRY28.SGD","PPH","LU2896262040.SGD","LU0345770993.USD","LLYZ","ELIL","LU2756315664.SGD","LU2417539215.USD","LU0889565916.HKD","BK4533","LU0882574139.USD","IE00BFSS8Q28.SGD","LU2237443978.SGD","LU2552382215.SGD","IE00BN29S564.USD","LU0289739699.SGD","THNR","LU0672654240.SGD","CANC","XLV","LU0823434740.USD","LLY","LU1127390331.HKD","LU2168563687.JPY","IHE","LU0820562030.AUD","LU0203202063.USD","LU1023059063.AUD","IE0004445239.USD","IE00BKDWB100.SGD","LU0820561818.USD","LU0471298777.SGD","MEDX","FHLC","LU0097036916.USD","LU0006306889.USD","LU0079474960.USD","LU0158827948.USD","LU1979441026.SGD","SGXZ31699556.SGD","LU2237443895.HKD","LU2462591350.SGD","LU2360106947.USD","LU0256863811.USD","LU1061106388.HKD","LLII","LU0943347566.SGD","LU2168564222.USD","LU2357305700.SGD","WDNA","LU0882574055.USD","IE00BJT1NW94.SGD","LU1232071149.USD","SG9999015952.SGD","SG9999014880.SGD","AGNG","BK4599","LU0353189763.USD","LU2468319806.SGD","LU1814569148.SGD","HRTS","RXL","LU2028103732.USD","LU1057294990.SGD","LU1551013342.USD","IE00B4JS1V06.HKD","LU2063271972.USD","LU2089283258.USD","SG9999014914.USD","LU2023250504.SGD","LU0354030438.USD","LU2237443622.USD","IE00B4R5TH58.HKD","LU0640476718.USD","LU1868837136.USD","LU2471134796.USD","BK4585","LU0256863902.USD","LU1623119135.USD","LU1868837300.USD","LU2750360641.GBP","LU0198837287.USD","BK4588","LU2552382132.HKD","IE0002141913.USD","IE0005OL40V9.USD","LU1989771016.USD","SGXZ57979304.SGD","SG9999015945.SGD","LU1868836914.USD","SGXZ99366536.SGD","LU1093756168.USD","LU1868836591.USD","OZEM","LU2756315318.SGD","IE00B2B36J28.USD","LU2237438978.USD","LU0058720904.USD","ILDR","IXJ","LU1291159041.SGD","LU2361044865.SGD","LU1720051108.HKD","LU2168564149.EUR","TRUH","LU0823416689.USD","LU2106854487.HKD","IE00BKPKM429.USD","LU2324357040.USD","LU2602419157.SGD","SG9999015986.USD","LU0471298694.HKD","LU2746668974.SGD","SG9999017495.SGD","SG9999015978.USD","LU2552382058.USD","LU0787776722.HKD","LU1720051017.SGD","LU1323610961.USD","LU0708995401.HKD","IE00BJLML261.HKD","LU0109394709.USD","LU0174119429.USD","LU1093756325.SGD","LU1988902786.USD","IE00BJJMRZ35.SGD","MHIP","SG9999001176.SGD","LU0786609619.USD","LU1917777945.USD","FTXH","SG9999001176.USD","LU0964807845.USD","SG9999018857.SGD","LU0823434583.USD","LLYX","LU2089984988.USD","LU2237443382.USD","LU2361044949.HKD","IE00B775H168.HKD","SGXZ81514606.USD","IE00BK4W5L77.USD","LU1145028129.USD","IE00BFSS7M15.SGD","LU2264538146.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673083010","title":"Eli Lilly treatment of pancreatic cancer granted orphan designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2673083010","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673083010?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:00","pubTimestamp":1791212411,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) was granted FDA orphan designation for olomorasib for the treatment of pancreatic cancer, according to a post to the agency’s websi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-treatment-of-pancreatic-cancer-granted-orphan-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-treatment-of-pancreatic-cancer-granted-orphan-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2360106947.USD","CURE","LU0122379950.USD","IE00BFSS8Q28.SGD","LU0787776722.HKD","LU1623119135.USD","LU0114720955.EUR","LU0266013472.USD","LU1551013425.SGD","LU0672654240.SGD","LU0354030511.USD","IE0004445015.USD","LU2213496289.HKD","LU0471298694.HKD","LU2168563687.JPY","LU0432979614.USD","LU0203201768.USD","LU1868836591.USD","JDOC","SG9999018857.SGD","RXL","LU2237443465.HKD","IE00BJJMRZ35.SGD","LU0234572021.USD","LU2168564065.EUR","IE0001KFT4U8.USD","LU0256863811.USD","BK4585","LU0820561909.HKD","LU1061106388.HKD","LLII","LU2028103732.USD","IE00B4R5TH58.HKD","LU2324357040.USD","LU2211815571.USD","SG9999018865.SGD","LU0323591593.USD","LU0786609619.USD","LU0708995401.HKD","LU1974910355.USD","SG9999017495.SGD","LU0689472784.USD","IE00B1XK9C88.USD","LU0203202063.USD","IE00BJT1NW94.SGD","IE00BJJMRY28.SGD","LU0964807845.USD","LU1868836757.USD","IE00BJJMRX11.SGD","PPH","SG9999001176.USD","LU0943347566.SGD","BK4581","BK4516","LU2361044865.SGD","LU2264538146.SGD","LU2087625088.SGD","IE00BJLML261.HKD","LU2089283258.USD","LU0466842654.USD","LU2491050071.SGD","PJP","LU2106854487.HKD","LU2471134523.USD","SG9999014880.SGD","IE00BK4W5M84.HKD","LU0882574055.USD","LU0210536198.USD","LU2168564495.EUR","LU0289739699.SGD","LU0109391861.USD","LU2746668974.SGD","SGXZ99366536.SGD","TMED","LU1989771016.USD","SG9999015978.USD","MEDX","LU2552382215.SGD","LU1323610961.USD","LU1093756168.USD","LU1291159041.SGD","IYH","LU1035775433.USD","LU1691799644.USD","LU0096364046.USD","LU2746668461.USD","LU0109394709.USD","LU1629891620.HKD","IE00B2B36J28.USD","LU1280957306.USD","LU1057294990.SGD","MEDI","LU0820561818.USD","LU0385154629.USD","TRUH","LU2756315664.SGD","LU0882574139.USD","IE00BWXC8680.SGD","LU2265009873.SGD","LU0320765992.SGD","LU0133085943.USD","BK4007","LU2237443622.USD","BK4534","SGXZ57979304.SGD","LU0094547139.USD","LU0889565916.HKD","LU2462591350.SGD","LU1983299246.USD","LU0097036916.USD","IE00BKDWB100.SGD","SG9999001176.SGD","SG9999015986.USD","SGXZ51526630.SGD","LU2462157665.USD","LU0061475181.USD","MHIP","FTXH","LU0225283273.USD","LU1366192091.USD","LU1814569148.SGD","LU2552382058.USD","LU0820562030.AUD","LU2237443978.SGD","SG9999015952.SGD","HRTS","IE00BFTCPJ56.SGD","LU1551013342.USD","LU2112291526.USD","LU0345770308.USD","LU2750360641.GBP","CANC","LU0823434740.USD","LU2237443549.SGD","IE0005OL40V9.USD","LU2361045086.USD","LU2237438978.USD","XLV","LU2491050154.USD","LU0256863902.USD","LU0320765059.SGD","LU0471298777.SGD","LU1127390331.HKD","LU2468319806.SGD","IE00BKPKM429.USD","LU2089984988.USD","LU2023250330.USD","LU1988902786.USD","VHT","LU0345770993.USD","LU2168564149.EUR","LU0456855351.SGD","IE0002141913.USD","LLY","LU2237443895.HKD","LU2357305700.SGD","LU2471134952.CNY","LU2461242641.AUD","LU2750360997.AUD","SG9999014898.SGD","IE0009355771.USD","IE00B4JS1V06.HKD","LU0316494557.USD","LU0354030438.USD","LU0158827948.USD","LU2552382132.HKD","GB00BDT5M118.USD","LU0058720904.USD","LU2756315318.SGD","ELIL","LU0158827781.USD","WDNA","OZEM","LU0106261372.USD","LU0640476718.USD","GDOC","LU1712237335.SGD","LU2237443382.USD","LU1023059063.AUD","LU1548497426.USD","SG9999014914.USD","LU1979441026.SGD","ILDR","LLYX","SGXZ81514606.USD","LU0079474960.USD","LU0683600562.USD","LU2361044949.HKD","BK4533","LU0353189680.USD","LU1868837136.USD","LU2168564222.USD","LU2023251221.USD","LU0823434583.USD","FHLC","LLYZ","LU2491049909.HKD","LU0823416689.USD","LU2111349929.HKD","IE00B1BXHZ80.USD","ELIS","THNR","LU1868837300.USD","SG9999014906.USD","LU1720051017.SGD","LU2471134879.HKD","LU0006306889.USD","IE00BK4W5L77.USD","IE00BN29S564.USD","LU1917777945.USD","AGNG","IE00BFSS7M15.SGD","LU2271345857.HKD","LU2456880835.USD","LU1064131342.USD","LU2063271972.USD","LU1804176565.USD","LU0198837287.USD","LU2089284900.SGD","SGXZ31699556.SGD","LU1868836914.USD","LU2236285917.USD","LU1232071149.USD","LU1145028129.USD","LU1267930730.SGD","LU2108987350.USD","IXJ","LU0174119429.USD","LU0417517546.SGD","LU1720051108.HKD","LU2602419157.SGD","LU1069344957.HKD","LU2471134796.USD","BK4599","BK4588","IE0004445239.USD","IHE","LU2896262040.SGD","LU0238689110.USD","IE00B775H168.HKD","IE00B7KXQ091.USD","SG9999015945.SGD","SG9999013999.USD","LU1093756325.SGD","LU2417539215.USD","LU0353189763.USD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673908348","title":"Analysts’ Top Healthcare Picks: Novartis (NVS), Crescent Biopharma (CBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673908348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673908348?lang=en_us&edition=fundamental","pubTime":"2026-10-05 22:40","pubTimestamp":1791211208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Novartis (NVS) and Crescent Biopharma (CBIO) with bu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-novartis-nvs-crescent-biopharma-cbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-novartis-nvs-crescent-biopharma-cbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","BK4137","XLV","BK4588","LABU","LU0208291251.USD","BK4532","LU0029874061.USD","MEDX","XBI","BK4139","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0070302665.USD","BK4007","LU0128526141.USD","BK4581","CBIO","LU0320765489.SGD","BK4578","NVS","PPH","LU0211331839.USD","IE0009355771.USD","BK4585","IE00B2B36J28.USD","IE00B4R5TH58.HKD","HCSG","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":5,"totalSize":278,"code":"91000000","status":"200"}]}}